Read The Lucky Years: How to Thrive in the Brave New World of Health Online
Authors: David B. Agus
genotyping of,
117
–18
immunotherapy for,
28
–33
inflammation in,
175
–77
measurement of success in treating of,
32
–33
metastasis in,
60
–62
molecular therapies for,
23
–24,
49
–50,
54
–55
muscle mass and,
195
p53 gene and,
57
–58
Peto’s paradox and,
57
plasma transfusions and,
5
precision medicine and,
115
radiation therapy for,
29
random mutations in,
169
–74,
176
as runaway cell copying,
59
self-seeding in,
61
statins and,
218
–20
treatment resistance in,
190
–91
Watson supercomputer and treatment of,
88
–89
see also specific types of cancer
cardiovascular disease,
86
,
121
,
128
,
147
,
216
airport noise and,
92
risk factors for,
47
Carnegie Mellon University,
214
CAR T cells,
29
–30
CBS This Morning,
67
Ceauşescu, Nicolae,
212
–13
Celebrex (celecoxib),
62
cell division,
5
cells:
death of (apoptosis),
59
endoplasmic reticulum in,
40
oxidative damage to,
40
receptors on,
59
Center for the Study of Aging and Human Development (Duke University),
45
Center for Translational Neuromedicine (University of Rochester),
208
Center for Translational Research in Aging and Longevity (University of Arkansas for Medical Sciences),
194
Centers for Disease Control and Prevention (CDC),
47
,
103
,
133
,
205
ceritinib (Zykadia),
53
change, self-assessment of, past vs. future in,
38
–40,
39
chaos theory,
236
–37
Charaka,
113
Charlottesville Neurology and Sleep Medicine,
204
checkpoint blockage therapy,
29
–30
Chicago, University of,
17
children, obesity and overweight in,
133
Chittagong University,
232
cholera,
234
dietary vs. blood,
162
online calculator for,
218
chronic disease,
128
–29
diet and,
141
–44
management of,
144
–46
overweight and,
141
sleep habits and,
147
chronological age,
45
,
46
,
46
,
47
,
135
–36,
232
circadian rhythm,
123
,
138
,
139
–40,
148
,
205
Circulation,
86
climate change,
159
Clinical Practice Research Datalink,
219
clinical trials,
52
IRBs and,
52
randomized,
52
–53
ClinVar,
9
cognitive dissonance,
159
Cohen, Jacques,
111
–12
Cold War,
94
Coley, William B.,
27
–29,
28
,
33
,
48
colitis,
121
–22
colonoscopies,
93
Colorado,
47
colorectal cancer,
55
,
123
–24,
190
,
217
statin use and,
220
Columbia University,
138
complex carbohydrates,
162
comprehensive metabolic panel (CMP),
151
context:
adapting to new data in,
159
aging and,
45
baselines for,
150
changes in,
22
data mining and,
101
health and,
48
,
76
–78,
84
,
89
–90,
91
–94,
101
,
113
,
114
–15,
117
,
124
–25
heart disease and,
22
identifying and optimizing,
135
–52
lab tests in,
150
–52
medical data and,
78
–82
medical education and,
75
Cooper Center Longitudinal Study,
192
coordination,
45
Cornell University,
2
coronary artery disease,
151
cortisol,
123
counterfeit drugs,
10
–11
C-reactive protein,
175
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats),
24
–25,
26
,
45
Critical Care,
222
CTLA-4,
29
–30
cystic fibrosis,
115
–16
Cystic Fibrosis Foundation Vertex,
115
–16
cytokines,
123
cytoplasm,
111
cytosol,
40
Dana-Farber Cancer Institute, Profile program of,
118
Dannon,
235
Dartmouth College,
157
Darwin, Charles,
112
data, medical:
context and,
78
–82
individual’s role in collection of,
81
security of,
88
–89
context and,
101
infectious diseases and,
100
–101
Davos, Switzerland,
161
Dawkins, Richard,
17
death, leading causes of,
129
death certificates,
96
dehydration,
234
dementia,
5
,
41
,
90
,
91
,
151
,
204
,
210
,
215
,
221
see also
Alzheimer’s disease
exercise and,
186
Dhaka,
232
diabetes,
22
,
24
,
25
,
47
,
59
,
108
,
114
,
123
,
128
,
147
,
151
,
166
,
175
,
186
,
187
,
188
,
215
,
221
,
237
gut bacteria and,
120
–21
incidence of,
120
–21
chronic disease and,
141
–44
as contextual,
163
honesty about,
133
–34
low-cholesterol,
162
low-fat,
162
moderation in,
144
research on,
see
nutritional studies
weight and,
141
diphtheria,
161
disease:
genetic markers for,
22
,
113
–14,
127
surrogate markers for,
127
–28
see also
chronic disease; infectious diseases; noncommunicable diseases
disorders, inherited, newborn screening and,
12
DNA,
see
genes, genome
docosahexaenoic acid (DHA),
182
dopamine,
211
Doudna, Jennifer A.,
25
dreaming,
203
drug abuse,
22
drugs,
see
medications
Duke Cancer Institute (DCI),
191
Duke University,
30
Center for the Study of Aging and Human Development at,
45
Dulken, Ben,
63
Dyerberg, Jorn,
182
–83
Dyson, Esther,
173
Earls, Felton,
213
Eat, Sleep, Poop
(Cohen),
137
eating patterns, heart disease and,
138
–40
E. coli,
123
eicosapentaenoic acid (EPA),
182
Elder, William, Jr.,
115
–16
electrodermal response,
230
–31
Elledge, Stephen J.,
84
emotions, touch and,
214
emulsifiers, microbiome and,
121
–22
“end of history illusion,”
38
–40,
39
End of Illness, The
(Agus),
18
endoplasmic reticulum,
40
endorphins,
211
energy levels,
149
England,
see
Great Britain
environment,
see
context
epidemics:
global spread of,
103
prediction of,
103
–4
epigenetics,
20
–21
esomeprazole (Nexium),
86
esophageal cancer,
217
estrogen,
64
ethics:
genome editing and,
24
–25
technology and,
25
–26
Europe,
77
European Journal of Immunology,
34
honesty about,
133
–34
ideal amount of,
196
–200
intensity of,
197
–98
life expectancy and,
189
–90
mortality rates and,
148
Exeter, University of,
157
“Experimental Prolongation of the Life Span” (McCay, Lunsford, and Pope),
2
experimental treatments, quicker access to,
56
Facebook,
27
fasting lipid profile,
150
feebleness, aging and,
43
fertility, aging and,
43
Field, Tiffany,
214
financial industry, information technology and,
89
Finland,
220
fish oil,
182
–83
Florida,
103
flu vaccine:
misinformation about,
157
–58
public distrust of,
160
FODMAPs (fermentable oligo-di-monosaccharides and polyols),
164
Fodor, George,
183
food, safety of,
11
Food and Drug Administration, US (FDA),
2
,
18
,
51
,
55
,
56
,
86
,
111
,
112
,
127
–28,
146
,
182
,
201
Accelerated Approval provisions of,
128
Foundation Medicine,
50
Fred Hutchinson Cancer Research Center,
169
free radicals,
208
fruit flies, eating pattern studies with,
138
–40
fungi,
119
gait,
45
galvanic skin response (GSR),
230
–31
gastroesophageal reflux disease (GERD),
86
Gates, Bill,
2
Genentech,
56